Description
Description: Venclyxto contains venetoclax, a BCL2 inhibitor used for treating chronic lymphocytic leukemia (CLL).
Contents: Each tablet contains 100mg of venetoclax.
Uses: Treatment of CLL and small lymphocytic lymphoma (SLL).
How it Works: Induces apoptosis (programmed cell death) in cancer cells by inhibiting BCL2 protein.
Directions for Use: Taken orally once daily, gradually increasing dosage as prescribed.
Side Effects:
- Neutropenia (low white blood cell count)
- Diarrhea
- Nausea
- Fatigue
Precautions:
- Regular blood tests to monitor blood counts.
- Not recommended for use during pregnancy or breastfeeding.
There are no reviews yet.